跳至主要内容
临床试验/NCT07708636
NCT07708636尚未招募不适用

UPRIGHT-PRO: Prospective Development Study of Upright Proton Therapy

Stanford University2 个研究点 分布在 1 个国家目标入组 450 人开始时间: 2026年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
450
试验地点
2
主要终点
Feasibility of upright proton therapy

研究概览

简要总结

This study is being done to evaluate whether cancer patients can safely and reliably receive proton radiation therapy while positioned upright. Proton therapy is an established form of radiation treatment, and the upright treatment system used in this study has been cleared by the U.S. Food and Drug Administration. The intent of this protocol is to observe the treatment methods, doses, and outcomes for the initial cohorts of patients treated with this upright device. This study will support research activities and evaluate feasibility as needed. Results of this study will be reported in the scientific literature but the investigators do not intend to report to the FDA for a new use or indication or change to the labeling; nor are the investigators required to do so.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Any cancer patient (children and adults) recommended for proton therapy.
  • Participation in other clinical trials is allowed (including randomized trials of protons versus other treatments)

排除标准

  • Any patient that doesn't meet the inclusion criteria

结局指标

主要结局

Feasibility of upright proton therapy

时间窗: End of proton therapy (3 months)

Feasibility is defined by the proportion of evaluable patients who complete a technically successful course of upright proton therapy. Technically successful course of upright proton therapy is defined as ≥80% of prescribed proton fractions delivered with upright proton therapy. Feasible if ≥70% of evaluable cases meet technically successful criterion.

次要结局

  • Quality of Life (FACT-G)(Baseline and end of proton therapy (3 months))
  • Treatment Satisfaction (FACIT-TS-G)(End of proton therapy (3 months))
  • Comfort/Stability Survey at Simulation(Baseline)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验